NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1

CUSIP: 64125CAD1

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Debt / NOTE 2.250% 5/1
Market price (% of par)
157.73%
Total 13F principal
$173,876,600
Principal change
+$15,817,600
Total reported market value
$275,007,176
Number of holders
36
Value change
+$25,405,051
Number of buys
16
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 64125CAD1?
CUSIP 64125CAD1 identifies 64125CAD1 - NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 as of Q4 2022

As of 31 Dec 2022, NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 was held by 36 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $173,876,600 in principal (par value) of the bond. The largest 10 bondholders included FRANKLIN RESOURCES INC, Invesco Ltd., WELLS FARGO & COMPANY/MN, LORD, ABBETT & CO. LLC, LORD, ABBETT & CO. LLC, Calamos Advisors LLC, FMR LLC, SSI INVESTMENT MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, and Paloma Partners Management Co. This page lists 37 institutional bondholders reporting positions for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.